Statement: There were 4% more cases (1 more case) of Dyspnea than Dehydration in the primary trial.
Primary_evidence: Adverse Events 1:   Total: 5/25 (20.00%)   Hypertension 1/25 (4.00%)   Dehydration 1/25 (4.00%)   Infection With Normal Anc Or Grade 1 Or 2 Neutrophils 2/25 (8.00%)   Pain 1/25 (4.00%)   Dyspnea (Shortness Of Breath) 2/25 (8.00%)